Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record.

Toluidine Blue Staining Identifies High-Risk Primary Oral Premalignant Lesions with Poor Outcome

Zhang, Lewei, Williams, Michele, Poh, Catherine F., Laronde, Denise, Epstein, Joel B., Durham, Scott, Nakamura, Hisae, Berean, Ken, Hovan, Alan, Le, Nhu D., Hislop, Greg, Priddy, Robert, Hay, John, Lam, Wan L., Rosin, Miriam P. · 2005 · Cancer Research

Abstract

There is a pressing need for the development of visual aids that will facilitate the detection of oral premalignant lesions (OPLs) with a high-risk of progression. Preliminary data suggest that toluidine blue stain may be preferentially retained by OPLs with high-risk molecular clones. In this study, we monitored OPLs from 100 patients without any history of oral cancer for an average of 44 months in order to evaluate the association of toluidine blue status with clinicopathologic risk factors, molecular patterns (microsatellite analysis on seven chromosome arms: 3p, 9p, 4q, 8p, 11q, 13q, and 17p) and outcome. Toluidine blue–positive staining correlated with clinicopathologic risk factors and high-risk molecular risk patterns. Significantly, a >6-fold elevation in cancer risk was observed for toluidine blue–positive lesions, with positive retention of the dye present in 12 of the 15 lesions that later progressed to cancer (P = 0.0008). This association of toluidine blue status with risk factors and outcome was evident even when the analysis was restricted to OPLs with low-grade or no dysplasia. Our results suggest the potential use of toluidine blue in identifying high-risk OPLs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-3153

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 176

Metadata

Authors
Zhang, L., Williams, M., Poh, C. F., Laronde, D., Epstein, J. B., Durham, S., Nakamura, H., Berean, K., Hovan, A., Le, N. D., Hislop, G., Priddy, R., Hay, J., Lam, W. L., & Rosin, M. P.
Venue
Cancer Research
Published
2005-09-01
Volume
65
Issue
17
Pages
8017-8021
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2117635193
Cited by
176
References
0
FWCI
12.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toluidine Blue Staining Identifies High-Risk Primary Oral Premalignant Lesions with Poor Outcome. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-3153
The paper
Zhang, L., Williams, M., Poh, C. F., Laronde, D., Epstein, J. B., Durham, S., Nakamura, H., Berean, K., Hovan, A., Le, N. D., Hislop, G., Priddy, R., Hay, J., Lam, W. L., & Rosin, M. P. (2005). Toluidine Blue Staining Identifies High-Risk Primary Oral Premalignant Lesions with Poor Outcome. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-3153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.